A nurse in a provider's office is preparing to teach a middle adult client who has a new diagnosis of metabolic syndrome and an HbA1c of 6 Which of the following medications should the nurse plan to teach the client about first?
Insulin glargine
Regular insulin
Exenatide
Metformin
The Correct Answer is D
A. Insulin glargine:
Insulin glargine is a long-acting insulin used to control blood sugar levels in people with diabetes. However, it is typically not the first-line choice for a client with a new diagnosis of metabolic syndrome and an HbA1c of 6.
B. Regular insulin:
Regular insulin is a short-acting insulin used to control blood sugar levels, but it is not typically the first choice for initial management of metabolic syndrome. It may be considered in certain situations, but other options are often explored first.
C. Exenatide:
Exenatide is a medication that belongs to the class of incretin mimetics and is used to improve blood sugar control. However, it may not be the first choice for initial treatment.
D. Metformin:
This is the correct answer. Metformin is a first-line medication for the treatment of type 2 diabetes and is commonly used to manage metabolic syndrome. It helps improve insulin sensitivity and reduce glucose production by the liver.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A. Transdermal: Epoetin alfa is not available for transdermal administration. It's a medication typically administered by injection.
B. Oral: Epoetin alfa is not orally active and is not available in oral form. The oral route is not suitable for this medication due to its large molecular size and degradation in the digestive system.
C. Intravenous (IV): This is the correct route for administering epoetin alfa. It is usually given as an intravenous injection in clinical settings.
D. Inhalation: Epoetin alfa is not formulated for inhalation. It is not administered through the respiratory system but rather through injection, most commonly intravenously.
Correct Answer is A
Explanation
A. Decrease in urine output:
This is the correct answer. Desmopressin is a synthetic form of antidiuretic hormone (ADH) that works to reduce urine output in individuals with diabetes insipidus. A decrease in urine output indicates a positive response to the medication.
B. Increase in serum glucose:
Desmopressin does not have a direct effect on serum glucose levels. Its primary action is to increase water reabsorption in the kidneys, reducing urine output.
C. Increase in WBC count:
Desmopressin does not have a direct impact on white blood cell (WBC) count. Its main action is on fluid balance and urine concentration.
D. Decrease in blood pressure:
Desmopressin can cause a mild increase in blood pressure, particularly at higher doses. However, blood pressure changes are not the primary therapeutic effect of desmopressin in the context of diabetes insipidus.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.